Misplaced Pages

Indium (111In) imciromab: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively
Page 1
Page 2
← Previous editContent deleted Content addedVisualWikitext
Revision as of 10:06, 31 October 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'CAS_number').← Previous edit Latest revision as of 00:30, 6 September 2024 edit undoInternetArchiveBot (talk | contribs)Bots, Pending changes reviewers5,382,301 edits Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5 
(11 intermediate revisions by 9 users not shown)
Line 2: Line 2:
{{Drugbox {{Drugbox
| Verifiedfields = changed | Verifiedfields = changed
| verifiedrevid = 450844591 | verifiedrevid = 458272134
| drug_name = Indium (<sup>111</sup>In) imciromab | drug_name = Indium (<sup>111</sup>In) imciromab
<!-- Monoclonal antibody data -->

<!--Monoclonal antibody data-->
| type = mab | type = mab
| mab_type = mab | mab_type = fab
| source = o | source = o
| target = cardiac ] | target = cardiac ]
<!-- Clinical data -->

| tradename = Myoscint
<!--Clinical data-->
| tradename =
| pregnancy_AU = | pregnancy_AU =
| pregnancy_US = | pregnancy_US =
Line 22: Line 20:
| legal_status = withdrawn | legal_status = withdrawn
| routes_of_administration = | routes_of_administration =
<!-- Pharmacokinetic data -->

<!--Pharmacokinetic data-->
| bioavailability = | bioavailability =
| protein_bound = | protein_bound =
Line 29: Line 26:
| elimination_half-life = | elimination_half-life =
| excretion = | excretion =
<!-- Identifiers -->

<!--Identifiers-->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} | ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = NA | ChemSpiderID = none
| CAS_number_Ref = {{cascite|correct|??}} | CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = <!-- blanked - oldvalue: 126132-83-0 --> | CAS_number = 126132-83-0
| CAS_supplemental = (imciromab) | CAS_supplemental = (imciromab)
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = UT2BA2O3KN
| ATC_prefix = V09 | ATC_prefix = V09
| ATC_suffix = GX02 | ATC_suffix = GX02
Line 41: Line 39:
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = | DrugBank =
<!-- Chemical data -->

<!--Chemical data-->
| chemical_formula = | chemical_formula =

| molecular_weight = | molecular_weight =
}} }}


'''Indium (<sup>111</sup>In) imciromab''' (trade name '''Myoscint''') is a ] ] labelled with the ] ].<ref></ref> It was used for ] imaging, but withdrawn in 1993.<ref></ref> '''Indium (<sup>111</sup>In) imciromab''' (trade name '''Myoscint''') is a ] ] labelled with the ] ].<ref></ref> It was used for ] imaging, but withdrawn in 1993.<ref>{{Cite web |url=http://www.diagnosticimaging.com/news/display/article/113619/1236557?verify=0 |title=DiagnosticImaging.com: Centocor withdraws imaging agent applications |access-date=2009-10-17 |archive-date=2012-02-26 |archive-url=https://web.archive.org/web/20120226065149/http://www.diagnosticimaging.com/news/display/article/113619/1236557?verify=0 |url-status=dead }}</ref>


==See also== ==See also==
Line 63: Line 59:


{{monoclonal-antibody-stub}} {{monoclonal-antibody-stub}}
{{nuclear-med-stub}}

]